Keywords: satisfactory, italy, recordati, italian, drugmaker, reported, sales
"Satisfactory" 1997 for Italy's Recordati
Article | 30 March 1998
Italian drugmaker Recordati has reported 1997 sales of 372.3 billionlira ($207 million), a rise of 5.2% compared with 1996. International revenues increased 11.4% to 159.1 billion lira, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
